Guardant Health Announces Proposed $300.0 Million Offering of Convertible Senior Notes Due 2033

Core Viewpoint - Guardant Health, Inc. plans to offer $300 million in aggregate principal amount of convertible senior notes due 2033 in a private offering to qualified institutional buyers under Rule 144A of the Securities Act of 1933 [1] Group 1 - The offering is aimed at raising capital through convertible senior notes [1] - The notes will be due in 2033, indicating a long-term financing strategy [1] - The offering is targeted at persons reasonably believed to be qualified institutional buyers, suggesting a focus on institutional investment [1]